Position in TNGX
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$186,928,735
+$89,611,113 QoQ
Shares Held
5,979,806
+28.5% QoQ
Ownership
3.55%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#12
of 247 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 12%
Shared 0%
None 88%
Common Shares in TNGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026STATE STREET CORP holds $36,552,510,511 across 411 Biotechnology names. TNGX ranks #50 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,871,459 | $5,896,909,829 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,834,688 | $3,014,621,355 | |
| 3 | INCY |
Incyte Corp
|
9,722,336 | $1,102,124,008 | |
| 4 | MRNA |
Moderna, Inc.
|
15,726,193 | $1,101,305,295 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,555,689 | $1,070,369,059 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
4,897,051 | $917,119,711 | |
| 7 | RPRX |
Royalty Pharma plc
|
12,338,229 | $691,804,500 | |
| 8 | INSM |
INSMED Inc
|
6,052,174 | $645,282,791 |
All Filings in TNGX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $186,928,735 | 5,979,806 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $97,317,622 | 4,651,894 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $55,096,503 | 6,218,567 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $28,267,722 | 3,365,205 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $7,079,352 | 1,382,686 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,567,886 | 1,144,443 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $3,804,404 | 1,231,199 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $17,850,201 | 2,318,208 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $15,686,462 | 1,828,259 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $22,756,818 | 2,866,098 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $9,691,486 | 978,938 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $10,740,677 | 953,879 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $2,984,477 | 898,939 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $3,245,039 | 821,529 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $6,118,050 | 843,869 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $3,158,819 | 872,602 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $3,362,782 | 742,336 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,873,275 | 247,134 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,516,123 | 229,993 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,561,433 | 198,100 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||